Therapeutic interchange of fluoxetine and sertraline: experience in the clinical setting.
Stock
A J
AJ
Department of Psychiatry, School of Medicine, University of South Dakota (USD), Sioux Falls.
Kofoed
L
L
D015057:1-Naphthylamine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000191:economics / Q000493:pharmacokinetics; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000191:economics / Q000493:pharmacokinetics*; D016527:Drug Costs; D005473:Fluoxetine / Q000008:administration & dosage / Q000191:economics / Q000493:pharmacokinetics*; D006801:Humans; D016134:Organizational Policy; D010607:Pharmacy Service, Hospital / Q000191:economics*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000191:economics / Q000493:pharmacokinetics*; D020280:Sertraline; D013810:Therapeutic Equivalency
D015057:1-Naphthylamine; D000928:Antidepressive Agents; D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline